Back to search
FDAFDA · Food and drugs·Recall number D-0504-2023

Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3

Published April 12, 2023 · Recall initiated: March 27, 2023

Summary

FDA records drug Class II recall D-0504-2023, published April 12, 2023 and initiated March 27, 2023. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 30 Bottles; Lot: Lot: G1822K, Exp. Date:5/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
Nationwide in the USA
Lot
Lot: G1822K, Exp. Date:5/31/2023.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3 recalled?

Yes. FDA published recall D-0504-2023 on April 12, 2023. Reported hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

What should I do if I have this product?

Voluntary: Firm initiated · Letter